2013 FDA Drug Approval Calendar
TheStreet.com
- Adcetris
- Amag Pharmaceuticals
- Amarin
- Antares
- Auxilium
- Aveo Pharmaceuticals
- Cubist Pharmaceuticals
- dabrafenib
- Delcath
- Depomed
- Dolutegravir
- drug approvals
- efinaconazole
- Entereg
- Feraheme
- Gilead
- GSK
- Melblez
- Merck
- Otrexup
- Seattle Genetics
- Sefelsa
- sofosbuvir
- suvorexant
- tivozanib
- Trametenib
- Valeant Pharmaceuticals
- Vascepa
- Xiaflex
- Zogenix
- Zohydro
Biotech Corner: Monoclonal Antibody Companies
Seeking Alpha
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe
Enhanced Online News
Seattle Genetics updates survival data from Adcetris trial for Hodkin lymphoma
Yahoo/Fly on the Wall
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech

